{
  "kind": "treatment",
  "slug": "droperidol-inapsine",
  "type": "antipsychotic",
  "name": "Droperidol (Inapsine)",
  "summary": "A butyrophenone antipsychotic primarily used for postoperative nausea/vomiting and agitation in emergency settings.",
  "description": "Droperidol is a dopamine D2 receptor antagonist of the butyrophenone class, related to haloperidol. While historically used as an antipsychotic, it is now most often employed in anesthesia and emergency medicine for rapid control of agitation and for prevention of postoperative nausea and vomiting (PONV). Its use has declined due to concerns about QT prolongation and risk of torsades de pointes.",
  "category": "medications/antipsychotics",
  "tags": [
    "butyrophenone",
    "antipsychotic",
    "sedative",
    "antiemetic"
  ],
  "metadata": {
    "drug_classes": [
      "Butyrophenone Antipsychotic",
      "Antiemetic"
    ],
    "therapeutic_categories": [
      "Psychosis",
      "Agitation",
      "Postoperative Nausea/Vomiting"
    ],
    "mechanism_categories": [
      "Dopamine Blocker"
    ],
    "administration_routes": [
      "Injection"
    ],
    "prescription_status": "Prescription Required",
    "controlled_substance": false,
    "generic_available": true,
    "brand_names": [
      "Inapsine"
    ],
    "dea_schedule": null,
    "fda_pregnancy_category": "C",
    "age_groups": [
      "Adult",
      "Geriatric"
    ],
    "treatment_duration": [
      "Acute"
    ],
    "specialty_areas": [
      "Emergency Medicine",
      "Anesthesiology",
      "Psychiatry"
    ],
    "fda_approval_year": 1970
  },
  "clinical_metadata": {
    "primary_indications": [
      "Other"
    ],
    "off_label_uses": [
      "Delirium management",
      "Adjunct for severe migraine"
    ],
    "contraindications": [
      "Known or suspected QT prolongation",
      "Severe CNS depression",
      "Hypersensitivity to droperidol or butyrophenones"
    ],
    "monitoring_required": [
      "ECG before administration",
      "Cardiac monitoring in high-risk patients"
    ],
    "efficacy_rating": {
      "agitation": 4,
      "nausea": 4
    }
  },
  "search_metadata": {
    "searchable_terms": [
      "droperidol",
      "inapsine",
      "butyrophenone",
      "antipsychotic",
      "antiemetic"
    ],
    "synonyms": [
      "droperidolum"
    ],
    "common_misspellings": [
      "droperidole",
      "dropeirdol"
    ]
  },
  "sections": [
    {
      "type": "indications",
      "items": [
        "Acute agitation (IM/IV)",
        "Postoperative nausea and vomiting (PONV)"
      ]
    },
    {
      "type": "mechanism",
      "text": "Antagonizes dopamine D2 receptors in the chemoreceptor trigger zone and mesolimbic pathway, reducing nausea and agitation. Also exhibits alpha-adrenergic blockade."
    },
    {
      "type": "dosing",
      "adult": {
        "agitation": "2.5–10 mg IM/IV, may repeat every 15–30 minutes as needed",
        "nausea_vomiting": "0.625–1.25 mg IV/IM administered at induction or end of surgery"
      },
      "geriatric": "Lower initial doses (e.g., 0.625 mg for nausea, 2.5 mg for agitation)",
      "hepatic_impairment": "Use with caution",
      "renal_impairment": "No adjustment necessary"
    },
    {
      "type": "dosage_forms",
      "items": [
        "Injection: 2.5 mg/mL (2 mL and 10 mL vials)"
      ]
    },
    {
      "type": "onset_duration",
      "text": "Onset within 3–10 minutes (IV) or 10–30 minutes (IM); duration 2–4 hours."
    },
    {
      "type": "adverse_effects",
      "common": [
        "drowsiness",
        "extrapyramidal symptoms",
        "hypotension"
      ],
      "less_common": [
        "akathisia",
        "restlessness"
      ],
      "serious": [
        "QT prolongation",
        "torsades de pointes",
        "neuroleptic malignant syndrome"
      ]
    },
    {
      "type": "warnings",
      "black_box": "Droperidol may cause QT prolongation and serious arrhythmias, including torsades de pointes. ECG monitoring is recommended.",
      "other": [
        "Avoid in patients with prolonged QT interval",
        "Caution with CNS depressants"
      ]
    },
    {
      "type": "interactions",
      "items": [
        {
          "with": "Other QT-prolonging drugs",
          "risk": "Additive QT prolongation",
          "action": "Avoid combination"
        },
        {
          "with": "CNS depressants",
          "risk": "Increased sedation",
          "action": "Use caution"
        },
        {
          "with": "Antihypertensives",
          "risk": "Additive hypotension",
          "action": "Monitor blood pressure"
        }
      ]
    },
    {
      "type": "monitoring",
      "items": [
        "Baseline ECG",
        "Continuous cardiac monitoring if high risk",
        "Vital signs after administration"
      ]
    },
    {
      "type": "special_populations",
      "pregnancy": "Use only if benefits outweigh risks; safety data limited",
      "lactation": "Excreted in breast milk; use with caution",
      "pediatrics": "Not routinely recommended except in anesthesia under specialist care",
      "geriatrics": "Increased sensitivity to hypotension and sedation"
    },
    {
      "type": "tapering",
      "text": "Not applicable for short-term use."
    },
    {
      "type": "clinical_notes",
      "items": [
        "Rapid onset makes it useful in emergency agitation management",
        "Often used in combination with benzodiazepines for severe agitation",
        "Has both antiemetic and sedative properties"
      ]
    },
    {
      "type": "references",
      "items": [
        {
          "label": "Inapsine Prescribing Information",
          "url": "https://www.accessdata.fda.gov/"
        },
        {
          "label": "American Society of Health-System Pharmacists Monograph",
          "url": "https://www.ashp.org/"
        },
        {
          "label": "Emergency Department Agitation Guidelines",
          "url": "https://www.acep.org/"
        }
      ]
    }
  ],
  "seo": {
    "title": "Droperidol (Inapsine): Uses, Dosing, Side Effects",
    "description": "Droperidol is a butyrophenone antipsychotic used for acute agitation and postoperative nausea/vomiting, with a black box warning for QT prolongation."
  }
}
